Tag Archives: aggressive

Promising new drug for aggressive stage IV breast cancer encounters setback

Federal approval of a highly anticipated breast cancer drug was delayed by the Food and Drug Administration this week. The drug, sacituzumab govitecan, which is produced by Immunomedics, was previously designated a “breakthrough therapy” by the FDA “based on preliminary evidence that it demonstrates substantial improvement over existing therapies for a life threatening disease.” According… Read More »

Roche scores win in slowing aggressive type of breast cancer

ZURICH/MUNICH (Reuters) – An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments have proven elusive, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals. FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel January 30,… Read More »